sameAs
P3781
Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD PatientsTiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary DiseaseCharacterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary DiseaseJapan Long-term Safety for Tiotropium Plus OlodaterolOlodaterol Bridging Study in AsthmaA Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe AsthmaEffects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPDThe ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a CombinationVahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary DiseaseBronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPDCo-administration of Olodaterol Respimat® and Tiotropium Handihaler® (2012-09-30)Early Intervention Efficacy in COPD
P4844
Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol.Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy.Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models.The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studies.24-hour bronchodilation following a single dose of the novel β(2)-agonist olodaterol in COPD.Olodaterol: first global approval.Current and novel bronchodilators in respiratory disease.Tiotropium sustains the anti-inflammatory action of olodaterol via the cyclic AMP pathway.Bronchoprotection by olodaterol is synergistically enhanced by tiotropium in a guinea pig model of allergic asthma.Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies.Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results
P921
Q61920878-B6A4BAB3-8ED9-4E2A-B9A2-FB5B18B4D334Q61975412-5F5EA748-F7EE-4F56-9C42-71B738092A10Q61975849-341809CA-3B18-4AC1-8A91-FA9C402B980EQ62062212-520210F0-26E8-4278-8C67-589B24A31D82Q63317173-2071E50E-8A35-4E14-892E-538E6FC2A7CBQ63320408-63A33735-8047-4169-9F27-A04B83420D18Q63320542-218D2041-6F5B-450C-9135-3CC52E213255Q63339119-099A96F9-A402-4B7C-B7BD-AB99D94B03B1Q63401737-CA8F3672-2DDF-45C0-A8DD-226E0890592AQ63573004-5621BA15-D15E-4F0D-8B88-8E4AC7D33252Q63574683-204B31A9-E6CD-4CA9-AD1E-8CB2FC336C8AQ63597758-7A738867-A057-4E64-B4F0-BFE677441E88Q86168395-A2602157-66E8-4B75-986D-D142E91CE673Q86294770-1517561C-9FF1-43E1-B320-764B2762B5E8
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Olodaterol
@es
Olodaterol
@sh
Olodaterol
@sr
Olodaterol
@vi
olodaterol
@en
olodaterol
@pl
olodaterolo
@it
أولوداتيرول
@ar
オロダテロール
@ja
type
label
Olodaterol
@es
Olodaterol
@sh
Olodaterol
@sr
Olodaterol
@vi
olodaterol
@en
olodaterol
@pl
olodaterolo
@it
أولوداتيرول
@ar
オロダテロール
@ja
altLabel
BI 1744
@en
BI-1744
@en
BI-1744-CL
@en
Olodaterol
@en
Striverdi®
@en
prefLabel
Olodaterol
@es
Olodaterol
@sh
Olodaterol
@sr
Olodaterol
@vi
olodaterol
@en
olodaterol
@pl
olodaterolo
@it
أولوداتيرول
@ar
オロダテロール
@ja
P486
P592
P6366
P661
P662
P665
P683
P1579
P2017
CC(C)(CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=CC3=C2OCC(=O)N3)O)O
P2067
386.184172
P2115
N0000190930
P2275
olodaterol
@en